Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 VaccineПодробнее

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| BreakingПодробнее

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trialsПодробнее

Covaxin, India’s First COVID-19 Vaccine, Cleared For Phase 3 Human TrialПодробнее

COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGIПодробнее

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 TrialПодробнее

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 DataПодробнее

COVID19 Vaccine | Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trialsПодробнее

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% EfficacyПодробнее

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy RateПодробнее

How Bharat Biotech’s COVID- 19 Vaccine Works/India's First indigenous COVID-19 VaccineПодробнее

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 TrialПодробнее

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under ReviewПодробнее

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial resultsПодробнее

Covid-19 Live News: Bharat Biotech Submits Covaxin's Phase-3 Trial Data To DCGI | Breaking NewsПодробнее

Covid vaccine: Bharat Biotech ends deal with Brazil; EU approves Moderna for kidsПодробнее

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia NewsПодробнее

77.8% efficacy of covaxin in phase 3 trial - Bharat biotechПодробнее

Covaxin: Bharat Biotech Granted Permission To Start Phase-3 Trials For Covid-19 VaccineПодробнее

Covid19 Vaccine Price: Centre Govt Asks Serum Institute, Bharat Biotech To Reduce Vaccine PriceПодробнее